LIPKOVÁ, Jolana and Kamil ĎURIŠ. The Role of microRNA in Ischemic and Hemorrhagic Stroke (The role of microRNA in ischemic and hemorrhagic stroke). Current Drug Delivery. Sharjah: Bentham Science Publishers, 2017, vol. 14, No 6, p. 816-831. ISSN 1567-2018. Available from: https://dx.doi.org/10.2174/1567201813666160919142212.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Role of microRNA in Ischemic and Hemorrhagic Stroke
Name in Czech Role microRNA u ischemické a hemoragické cévní mozkové příhody
Authors LIPKOVÁ, Jolana (203 Czech Republic, guarantor, belonging to the institution) and Kamil ĎURIŠ (203 Czech Republic, belonging to the institution).
Edition Current Drug Delivery, Sharjah, Bentham Science Publishers, 2017, 1567-2018.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Arab Emirates
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.078
RIV identification code RIV/00216224:14110/17:00094602
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.2174/1567201813666160919142212
UT WoS 000409883200010
Keywords (in Czech) microRNA, ischemické cévní mozková příhoda, hemoragická cévní mozková příhoda
Keywords in English Central nervous system; embolectomies; hemorrgahic stroke; ischemic stroke; microRNA; thrombolysis
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 13:17.
Abstract
Background: Stroke is the second leading cause of death worldwide. Understanding of gene expression dynamics could bring new approaches in diagnostics and therapy of stroke. Small noncoding molecules termed "microRNA" represent the most flexible network of gene expression regulators. Method: The aim of this review was to briefly describe the structure and function of microRNA and summarize the current knowledge about the involvement of microRNAs in the pathophysiology of ischemic and hemorrhagic stroke based on both experimental and clinical studies. Results: Numerous profiling studies identified candidate microRNAs and partially described dynamics of their expression after the stroke. However, complex associations of specific microRNAs expression with main clinical characteristics and deeper insight into mechanisms of their regulatory functions are still missing. In this review, we put special emphasis on several microRNA clusters involved in neuroprotection (miR-124, miR-181, miR-21, miR-29, miR-210 and let7). Potential application of microRNAs as biomarkers and diagnostic or therapeutic targets was also discussed. Conclusion: Full understanding of the regulatory mechanisms of the microRNA networks represents a novel direction for stroke research. To date, we do not have effective tools to control pathophysiological processes associated with stroke. Thus the microRNAs have to be considered as a very promising target for future stroke therapies.
Links
GP14-23773P, research and development projectName: Regulace zánětlivé odpovědi prostřednictvím mikroRNA na experimaentálním modelu subarachnoidálního krvácení
Investor: Czech Science Foundation
PrintDisplayed: 20/7/2024 09:38